Alex Davis has represented both investment banks and issuers on capital markets and corporate transactions, including initial public offerings, other equity offerings, convertible debt offerings and acquisition financings. Alex also advises public companies with respect to general corporate and securities matters, including Exchange Act reporting obligations and corporate governance issues.

Download full bio 


  • Structure Therapeutics – $185.3 Million IPO 

  • Ascendis Pharma – $575 Million Convertible Senior Notes Offering 

  • Lulu’s – $92 Million IPO 

  • Rani Therapeutics – $73 Million IPO 

  • Janux Therapeutics – $194 Million IPO 

  • View all


  • Columbia Law School
    JD, Harlan Fiske Stone Scholar, 2017

  • San Diego State University
    BS, Finance
    magna cum laude, 2014

Admissions & Credentials



  • State Bar of California

  • San Diego County Bar Association